BONU Financials Tuesday, July 15, 2014 06:11:07 AM
Post# of 17
BioNeutral Group, Inc.
Period Ending Oct 31, 2013 Oct 31, 2012 Oct 31, 2011 Oct 31, 2010
Total Revenue 21 5 54 16
Cost of Revenue 15 2 21 12
Gross Profit 7 2 33 3
Operating Expenses
Research and Development - - - 265
Sales, General and Admin. 1,983 1,550 1,682 1,564
Non-Recurring Items 381 284 548 1,224
Other 709 709 707 697
Operating Income (3,066) (2,540) (2,904) (3,746)
Income From Continuing Operations
Add'l Income/Expense Items 90 - - -
Earnings Before Interest and Tax (2,977) (2,540) (2,904) (3,746)
Interest Expense 214 66 156 87
Earnings Before Tax (3,191) (2,606) (3,061) (3,833)
Income Tax - - - -
Minority Interest (269) (220) (242) (332)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,921) (2,386) (2,819) (3,502)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,921) (2,386) (2,819) (3,502)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,921) (2,386) (2,819) (3,502)